Impact of a planned dose interruption of dacomitinib in the treatment of advanced non-small-cell lung cancer (ARCHER 1042).
暂无分享,去创建一个
M. Lacouture | Dong-Wan Kim | B. Cho | A. Jatoi | S. Sonis | E. Garon | N. Giri | D. Keefe | S. Nadanaciva | J. O'Connell | Tao Wang | D. Gernhardt | E. Sbar | J. Doherty